Clinical Trials
3 trialsNCT02632994 2025-09-29
Master Rollover Protocol for Continued Safety Assessment of Study Drug
Eli Lilly and Company
Available
NCT02124148 2020-04-01
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT02536586 2018-07-24
A Study of LY3023414 in Japanese Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed